The Danis Stent is a worldwide unique self-expandable covered esophageal stent that is the only one officially indicated to stop bleeding from esophageal varices.
Its dimensions and high expansion force represent a very effective and easy solution for patient stabilization.
The delivery system has been developed to allow the stent to be implanted in an acute situation without endoscopic and X-ray control.
Recommended by several international procedures and guidelines for the treatment of esophageal varices.
The Danis Stent is intended for patients aged 16 and older and is indicated to stop acute and/or refractory bleeding from esophageal varices.
The open lumen of the esophagus allows the physician to perform other endoscopic procedures and allows the patient to eat.
The unique design of braiding of this stent is adapted to esophageal peristalsis and reduces the risk of migration.
Clinical and technical efficacy of the stent is in the range of 95 to 100%.
Patient stabilization and hemostasis for 7 days after implantation.
Compatibility with the ELLA Extractor ensures atraumatic stent removal, which significantly reduces recurrence of bleeding.
MRI compatibility - "MR Conditional", compatible with 1.5 Tesla and 3 Tesla static magnetic field.
Easy implantation in 7 steps.
The delivery system is equipped with a scale and a balloon for precise stent placement.
Special indication balloon to prevent potential complications.
The stent is delivered sterile compressed in a delivery system. The 0.035 ”(0.89 mm) / 260 cm ultra stiff guidewire included in the package is used for insertion, as well as a 50 ml syringe.